[Scleroderma, scleroderma related diseases].
Kondo
H
H
Department of Internal Medicine, Kitasato University School of Medicine.
D000814:Aniline Compounds / Q000009:adverse effects; D000818:Animals; D001761:Bleomycin / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use; D003937:Diagnosis, Differential; D016603:Eosinophilia-Myalgia Syndrome / Q000209:etiology / Q000503:physiopathology; D004853:Epoxy Resins / Q000009:adverse effects; D006801:Humans; D016273:Occupational Exposure / Q000009:adverse effects; D011143:Polyvinyl Chloride / Q000009:adverse effects; D011379:Prognosis; D012595:Scleroderma, Systemic / Q000209:etiology / Q000503:physiopathology; D012822:Silicon Dioxide / Q000009:adverse effects; D012828:Silicones / Q000009:adverse effects; D012997:Solvents / Q000009:adverse effects; D014364:Tryptophan / Q000009:adverse effects
D000814:Aniline Compounds; D004853:Epoxy Resins; D012828:Silicones; D012997:Solvents; D001761:Bleomycin; D012822:Silicon Dioxide; D014364:Tryptophan; D011143:Polyvinyl Chloride; D002230:Carbidopa; C023650:aniline